- Filed
- May 13, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 12, 2025 | 17.18M sh |
| Short Term Investments | Q1 2025 · Mar 31, 2025 | $1.43M |
| Short Term Investments | Q1 2025 · Dec 31, 2024 | $2.91M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $622.03K |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $574.49K |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $574.74K |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $546.69K |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $574.74K |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $546.69K |
| Current Assets | Q1 2025 · Mar 31, 2025 | $2.62M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $3.96M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $2.9M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $4.22M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 7.44M sh |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$763.29K |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $2.33M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $3.21M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.14 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.14 |
| Sga Expense restated | Q1 2025 · Mar 31, 2024 | $483.31K |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $105.67K |
| Net Income | Q1 2025 · Mar 31, 2024 | −$1.04M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$1.07M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $69.52K |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $9.16K |
| Revenue | Q1 2025 · Mar 31, 2024 | $78.67K |